Melzo, Italy

Elio Mapelli

This inventor holds 1 USPTO granted patent. Top assignee: Antibioticos. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elio Mapelli. Retrieved from https://idiyas.com/inventor/elio-mapelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elio Mapelli: Innovator in Anthracycline Derivatives

Introduction

Elio Mapelli is a notable inventor based in Melzo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anthracycline derivatives. His work is characterized by a focus on innovative processes that enhance the efficacy of medicinal compounds.

Latest Patents

Elio Mapelli holds a patent for a process for the preparation of anthracycline derivatives. This invention discloses a method for the semi-synthesis of 4-demethoxydaunomycinone, specifically the compound known as (8s-cis)-acetyl-10-hydroxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-5,12-naphthacenedione. This process is crucial for advancing the development of effective cancer treatments.

Career Highlights

Elio Mapelli is currently associated with Antibioticos S.p.a., where he continues to innovate in the pharmaceutical sector. His expertise in the synthesis of complex chemical compounds has positioned him as a valuable asset in his field. With a focus on improving therapeutic agents, he has contributed to the advancement of medical science.

Collaborations

Elio has worked alongside talented colleagues such as Valentina Pizzamiglio and Walter Cabri. Their collaborative efforts have fostered an environment of innovation and creativity, leading to significant advancements in their projects.

Conclusion

Elio Mapelli's contributions to the field of anthracycline derivatives exemplify the impact of innovative thinking in pharmaceuticals. His patent and ongoing work at Antibioticos S.p.a. highlight his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…